官方服务：
资源简介：
Resistance mutations and ART use.
应用场景：
创建时间：
2017-05-11
相关数据集
The cumulative exposure durations of antiretroviral agents of the two study populations.
Note: The comorbidities include hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, chronic kidney disease (eGFR2), malignancy, osteoporosis, and chronic viral hepatitis.Abbrevia
Figshare2015-12-02 更新20
MANCOVA’s main and interactive effect results.
The introduction of antiretroviral therapy (ART) has successfully changed the clinical course of people with HIV, leading to a significant decline in the incidence of HIV-related neurocognitive disord
NIAID Data Ecosystem20
Frequency of HIV-1 drug-resistance mutations in ART-experienced and -naïve adult patients (≧15 years old) ( n = 90) a .
ART, antiretroviral therapy; NNRTI, non-nucleoside reverse-transcriptase inhibitor; NRTI, nucleoside reverse-transcriptase inhibitor; PI, protease inhibitor; and TAMs, thymidine analog-associated muta
NIAID Data Ecosystem20
Patient characteristics at ART initiation and treatment outcomes for patients initiating a tenofovir based regimen at the Themba Lethu Clinic in Johannesburg, South Africa.
*Among patients with at least 1 viral load between 1 month and 1 year after ART initiation. +Among patients with at least 1 viral load after 4 months on treatment.
NIAID Data Ecosystem20
NNRTI-resistance results obtained through phenotypic testing, direct sequencing and ultra-deep sequencing (UDPS).
ETR = etravirine; Direct = Direct Sanger sequencing; UDPS = Ultra-Deep Pyrosequencing; Stan = Stanford; Tibo = Tibotec; Mono = Monogram. *figure beneath amino acid indicate percentage cons
NIAID Data Ecosystem20
